Chemoinformaics analysis of (S)-CHEILANTHIFOLINE
| Molecular Weight | 325.364 | nRot | 1 |
| Heavy Atom Molecular Weight | 306.212 | nRig | 25 |
| Exact Molecular Weight | 325.131 | nRing | 5 |
| Solubility: LogS | -1.86 | nHRing | 3 |
| Solubility: LogP | 2.636 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 48.7071 |
| nHD | 1 | BPOL | 25.9789 |
| QED | 0.874 |
| Synth | 3.119 |
| Natural Product Likeliness | 1.366 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.072 |
| Pgp-sub | 0.201 |
| HIA | 0.002 |
| CACO-2 | -5.013 |
| MDCK | 0.0000285 |
| BBB | 0.983 |
| PPB | 0.952732 |
| VDSS | 1.189 |
| FU | 0.0413946 |
| CYP1A2-inh | 0.925 |
| CYP1A2-sub | 0.852 |
| CYP2c19-inh | 0.747 |
| CYP2c19-sub | 0.775 |
| CYP2c9-inh | 0.031 |
| CYP2c9-sub | 0.539 |
| CYP2d6-inh | 0.98 |
| CYP2d6-sub | 0.925 |
| CYP3a4-inh | 0.835 |
| CYP3a4-sub | 0.872 |
| CL | 20.025 |
| T12 | 0.516 |
| hERG | 0.201 |
| Ames | 0.566 |
| ROA | 0.603 |
| SkinSen | 0.617 |
| Carcinogencity | 0.886 |
| EI | 0.019 |
| Respiratory | 0.868 |
| NR-Aromatase | 0.074 |
| Antiviral | Yes |
| Prediction | 0.726464 |